Neumora Therapeutics, Inc. Common Stock

NMRA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$129,071$124,523$126,860$142,148
Short-Term Investments$42,454$93,065$122,493$165,430
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$5,557$5,321$5,513$6,477
Total Curr. Assets$177,082$222,909$254,866$314,055
Property Plant & Equip (Net)$554$618$1,882$2,917
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$197$298$0$0
Total NC Assets$751$916$1,882$2,917
Other Assets$0$0$0$0
Total Assets$177,833$223,825$256,748$316,972
Liabilities
Payables$549$644$1,052$3,307
Short-Term Debt$256$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$25,037$6,733$6,281$10,108
Total Curr. Liab.$25,842$21,156$28,384$29,886
LT Debt$267$19,451$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$19,563$0$0$22
Total NC Liab.$19,830$19,790$0$22
Other Liabilities$0$0$0$0
Cap. Leases$523$510$938$1,853
Total Liabilities$45,672$40,946$28,384$29,908
Equity
Pref Stock$0$0$0$0
Common Stock$16$16$16$16
Retained Earnings-$1,124,699-$1,067,944-$1,015,213-$947,221
AOCI$9-$15-$3$62
Other Equity$1,256,835$0$0$0
Total Equity$132,161$182,879$228,364$287,064
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$177,833$223,825$256,748$316,972
Net Debt-$128,548-$105,072-$126,860-$142,148